Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Izalontamab |
Trade Name | |
Synonyms | SI-B001|SI B001|SIB001 |
Drug Descriptions |
Izalontamab (SI-B001) is a bispecific antibody targeting EGFR and ERBB3 (HER3), which potentially inhibits tumor growth (PMID: 32565357). |
DrugClasses | EGFR Antibody 60 HER3 (ERBB3) Antibody 23 |
CAS Registry Number | 2559704-24-2 |
NCIT ID | C178396 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Carboplatin + Izalontamab + Pemetrexed Disodium | Carboplatin Izalontamab Pemetrexed Disodium | 0 | 0 |
Docetaxel + Izalontamab | Docetaxel Izalontamab | 0 | 0 |
Izalontamab | Izalontamab | 0 | 0 |
Izalontamab + Paclitaxel | Izalontamab Paclitaxel | 0 | 0 |